Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Topics
»
Disease categories and therapies
» Inflammatory
Inflammatory
RSS
Spingotec Therapeutics divulges DPP3 inhibitors
Nov. 22, 2017
First-in-human results provided for TR-Pharm's anti-interleukin-1 biologic RPH-104
Nov. 15, 2017
New yohimbine analogues synthesized at the University of Florida
Nov. 15, 2017
Novel NLRP3 inflammasome inhibitors presented by IFM Therapeutics
Nov. 3, 2017
Novel leukotriene A-4 hydrolase inhibitors identified at Novartis
Oct. 31, 2017
Allergan presents new fMet-Leu-Phe receptor modulators
Oct. 30, 2017
University of Texas, Immune Sensor divulge new cyclic GMP-AMP synthase inhibitors
Oct. 19, 2017
Blade Therapeutics patents novel calpain inhibitors
Oct. 4, 2017
Galapagos presents new sphingosine 1-phosphate receptor antagonists
Sep. 19, 2017
Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation
Sep. 19, 2017
Previous
1
2
…
88
89
90
91
92
93
94
95
96
97
98
99
Next
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe